Source: Science translational medicine. Unidade: FM
Subjects: VETORES, FEBRE AMARELA, BRASIL
ABNT
RICCIARDI, Michael J et al. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, v. 15, n. 689, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53922. Acesso em: 20 ago. 2024.APA
Ricciardi, M. J., Rust, L. N., Pedreno-lopez, N., Yusova, S., Biswas, S., Webb, G. M., et al. (2024). Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, 15( 689). doi:10.1126/scitranslmed.ade5795NLM
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2024 ago. 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922Vancouver
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2024 ago. 20 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922